A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effectsin vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effectsin vitro

Published:2015-12-24 Issue:4 Volume:71 Page:964-974
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Clewe Oskar,Aulin Linda,Hu Yanmin,Coates Anthony R. M.,Simonsson Ulrika S. H.

Funder

Swedish Research Council

Innovative Medicines Initiative Joint Undertaking

European Union's Seventh Framework Programme

EFPIA companies

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/4/964/17429690/dkv416.pdf

Reference48 articles.

1. World Health Organization. Global Tuberculosis Report 2014 . http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf .

2. Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments

3. Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

4. Evaluation of the pharmacokinetics–pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection

5. Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosa

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin;British Journal of Clinical Pharmacology;2024-04-17

2. Model‐based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug‐resistant tuberculosis;British Journal of Clinical Pharmacology;2023-10-26

3. Characterization of spectinamide 1599 efficacy against different mycobacterial phenotypes;Tuberculosis;2023-05

4. Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development;Frontiers in Pharmacology;2023-04-13

5. Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium;iScience;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3